[图书][B] The genetic basis of haematological cancers
S Tosi, AG Reid - 2016 - books.google.com
Written by a team of international experts, this book provides an authoritative overview and
practical guide to the molecular biology and genetic basis of haematologic cancers …
practical guide to the molecular biology and genetic basis of haematologic cancers …
[PDF][PDF] Atypical patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in patients with chronic myeloid leukemia
Fluorescent in situ hybridization (FISH) technique is increasingly used for the identification of
BCR/ABL gene rearrangements in chronic myeloid leukemia (CML). Patients and Methods …
BCR/ABL gene rearrangements in chronic myeloid leukemia (CML). Patients and Methods …
[HTML][HTML] Clinical and hematological characteristics of patients with chronic myeloid leukemia under present-day conditions: results of the Russian part of International …
OV Lazareva, AG Turkina, EY Chelysheva… - Clin …, 2017 - old.bloodjournal.ru
Background. Much attention has been paid to molecule-genetic diagnostics of chronic
myeloid leukemia (CML) and its treatment using new highly effective methods of therapy …
myeloid leukemia (CML) and its treatment using new highly effective methods of therapy …
[HTML][HTML] Molecular genetics of chronic myeloid leukemia
RA Van Etten - UpToDate. Waltham, MA: UpToDate, 2009 - medilib.ir
INTRODUCTION—Chronic myeloid leukemia (CML, also known as chronic myelocytic,
myelogenous, or granulocytic leukemia) is classified as one of the myeloproliferative …
myelogenous, or granulocytic leukemia) is classified as one of the myeloproliferative …
甲磺酸伊马替尼对慢性髓系白血病患者效果的相关因素研究
王良妥, 张湘兰, 司徒健瑜, 黄远颖 - 安徽医药, 2016 - ahyyzz.cn
目的研究甲磺酸伊马替尼对慢性髓系白血病(CML) 患者效果的相关因素. 方法2010 年1
月至2015 年3 月, 该院接收70 例慢性髓系白血病患者口服甲磺酸伊马替尼400~ 600 mg· d-1 …
月至2015 年3 月, 该院接收70 例慢性髓系白血病患者口服甲磺酸伊马替尼400~ 600 mg· d-1 …
Genomic alterations in myeloid neoplasms with novel, apparently balanced translocations
JL Poitras, D Costa, MJ Kluk, PC Amrein, RM Stone… - Cancer Genetics, 2011 - Elsevier
Characterization of gross chromosomal rearrangements, particularly translocations in
neoplasms, has proven to be valuable in patient management by aiding in diagnosis …
neoplasms, has proven to be valuable in patient management by aiding in diagnosis …
[PDF][PDF] Diagnostyka i ocena skuteczności leczenia przewlekłej białaczki szpikowej
T Sacha, K Foryciarz - Hematologia, 2010 - ruj.uj.edu.pl
W diagnostyce przewlekłej białaczki szpikowej (CML) wykorzystywane są badania
morfologiczne krwi obwodowej i szpiku kostnego, badania cytogenetyczne oraz badania …
morfologiczne krwi obwodowej i szpiku kostnego, badania cytogenetyczne oraz badania …
Bringing prognostic scores for chronic myeloid leukemia patients up to date
M Breccia, G Alimena - Expert Review of Hematology, 2011 - Taylor & Francis
The advent of tyrosine kinase inhibitors (TKIs) has dramatically changed chronic myeloid
leukemia (CML) outcome. Imatinib has resulted in over 80 and 70% complete cytogenetic …
leukemia (CML) outcome. Imatinib has resulted in over 80 and 70% complete cytogenetic …
Characterization and significance of the Philadelphia negative/BCR-ABL1 positive rearrangement or masked Philadelphia translocation in patients with chronic …
B Ratajczak, M Gniot… - Leukemia & …, 2020 - Taylor & Francis
Karyotype with the presence of a cryptic rearrangement involving the BCR-ABL1 fusion
gene may be found in chronic myeloid leukemia (CML) patients with apparently normal …
gene may be found in chronic myeloid leukemia (CML) patients with apparently normal …